Optogenetic Treatment Restores Partial Vision in Retinitis PigmentosaMay 24th 2021
An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that could restore vision.
Collaboration formed to develop AAV-based gene therapies for eye diseaseJanuary 6th 2021
ViGeneron and Biogen this week have announced a global collaboration and licensing agreement in which the partners will develop and commercialize gene therapy products based on adeno-associated virus (AAV) vectors that treat inherited eye disease.